跳至主要内容
临床试验/NCT02007759
NCT02007759终止不适用

Randomized Treatment of Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates

Sanford Health2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2013年11月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
12
试验地点
2
主要终点
Increased percent of subjects towards achieving full oral feedings earlier in the subject's dysphagia treatment.

研究概览

简要总结

The purpose of this study is to evaluate if the use of Neuromuscular Electrical Stimulation (NMES) will provide a more efficient method of treating neonates with dysfunctional oral feeding such as dysphagia. This study will attempt to determine if NMES applied to neonates at 36-42 weeks post-conception age (PCA) will decrease the need for nasogastric tubes (NG) and gastrostomy tubes (G-TUBE). Increase the rate at which these neonates complete full oral feeds, improve their swallowing skills, increase oral intake of calories, and gain weight.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
36 Weeks 至 42 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Male or female.
  • Meet diagnostic criteria for dysphagia symptoms using the NOMAS and a VFSS.
  • Infants with intraventricular hemorrhage (IVH) and hypoxic events can be included.
  • Infants taking less than 5-10% of target volume by mouth between the ages of 36-42 weeks PCA.
  • Multiple swallows to clear bolus following suck that includes a desaturation <80% and bradycardia <80 bpm.
  • Apnea spells during feeds.
  • Aspiration or penetration by VFSS

排除标准

  • Known neurologic or neurodegenerative disorders.
  • Chromosomal anomalies and syndromes.
  • Cleft lip or palate.
  • Birth defects.
  • Unresolved cutaneous rash at the area of electrode placement.
  • Medical condition that is a contraindication to NMES.

研究组 & 干预措施

VitalStim

Experimental

This group will be assigned to the active VitalStim unit.

干预措施: VitalStim (Device)

Sham VitalStim

Sham Comparator

This group will be assigned to the sham VitalStim unit.

干预措施: Sham VitalStim (Device)

结局指标

主要结局

Increased percent of subjects towards achieving full oral feedings earlier in the subject's dysphagia treatment.

时间窗: Over the course of the treatment time frame to discharge, 2 weeks to 8 weeks

Earlier NG tube removal for the treatment group compared to the control group.

时间窗: Over the course of the treatment time frame to discharge, 2 weeks to 8 weeks

Increase the amount of formula volume taken at feedings from beginning to end of study.

时间窗: 2 weeks

Reduction in G-tube rate insertions for the treatment grouped compared to the sham group.

时间窗: Over the course of the treatment time frame to discharge, 2 weeks to 8 weeks

次要结局

  • Decrease inpatient length of stay.(4 weeks)
  • Decrease spells with oral feeds over the course of the study.(2 weeks)
  • Allow for healthy weight gain via improved feedings.(2 weeks)
  • Increase the caloric intake orally.(2 weeks)
  • Decrease the oxygen requirement before and after study.(2 weeks)
  • Improve swallowing skills as measured by videofluoroscopic swallowing study (VFSS) and the video swallow assessment worksheet.(2 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验